Weave Communications, Inc. beat Q4 2024 earnings estimates, targets $10B market with AI-driven innovations in healthcare communications. Read my latest WEAV stock update.
Hailed as the first Chinese company to launch a homegrown antibody drug conjugate (ADC), RemeGen has recently been battling a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback